SEARCH
SEARCH
Patient Group Accelerator
Contact
Solutions
Decentralised Clinical Trials
Hybrid Clinical Trials
Remote Patient Monitoring
Sectors
For Biotechs
For Pharma
For CROs
For Academics
For Patient Groups
Atom5™ Platform
Patient App & Portal
Clinical Portal
eCOA
Data Analytics
Regulatory Compliance
Therapy Areas
Ataxia studies
Neurodegenerative
Paediatric studies
Rare Disease
Publications
Journals & Papers
Posters
Presentations
White Papers
Case Studies
About Aparito
Contact
The Team
Pipeline
Partnerships
Success Stories
News
Press release
Clear Filter
Press release
Blood-thinning drug used to treat severe COVID recovery not effective
Published: 30/11/2022
View
digitises clinical trials
Terms of Use
Privacy Policy
© Aparito Limited trading as Aparito - Registered in the UK Company Number: 09285366
Registered Office: Unit 11 Wrexham Technology Park Wrexham LL13 7YP
